| Nazwa produktu | Nefiracetam |
| Synonimy | DM-9384; DMMPA; DZL-221; Translon; N-(2,6-Dimethylphenyl)-2-oxo-1-pyrrolidineacetamide; 2-(2-Oxopyrrolidin-1-yl)-N-(2,6-dimethylphenyl)acetamide |
| Numer CAS | 77191-36-7 |
| Wzór cząsteczkowy | C₁₄H₁₈N₂O₂ |
| Masa cząsteczkowa | 246.30 g/mol |
| Wygląd | Biały lub prawie biały krystaliczny proszek |
| Oznaczenie (HPLC) | ≥ 99,01 TP3T |
| Temperatura topnienia | 125–129°C |
| Strata przy suszeniu | ≤ 0,5% |
| Popiół po spaleniu | ≤ 0,11 TP3T |
| Metale ciężkie | ≤ 10 ppm |
| Przechowywanie | W chłodnym, suchym miejscu, w zamkniętym opakowaniu, chronione przed światłem |
Potrzebujesz pomocy? Skontaktuj się z naszym zespołem
Nefiracetam (developmental code DM-9384) is a lipid-soluble nootropic compound belonging to the racetam family.
It is structurally distinct from other racetams due to the presence of a 2,6-dimethylphenyl group attached to the acetamide moiety.
This structural modification confers unique pharmacological properties, including GABAergic modulation (distinguishing it from most other racetams) and neuroprotective effects.
cecha wyróżniająca: Unlike most racetams that act primarily through glutamatergic (AMPA) modulation, Nefiracetam has demonstrated significant GABAergic activity, particularly at GABA-A receptors. This unique dual mechanism (GABAergic + glutamatergic) makes Nefiracetam particularly interesting for research into anxiety, neuroprotection, and cognitive disorders with an anxiety component.
Słowa kluczowe:Nefiracetam CAS 77191-36-7, DM-9384, DMMPA, Translon, GABA-A modulator, dual-mechanism nootropic, neuroprotection research, racetam family, calcium channel inhibitor, LyvBio Nefiracetam
Racetam Family Comparison:
| Związek | Solubility | Primary Mechanism | Unique Property |
|---|---|---|---|
| Piracetam | Water | AMPA (weak) | Parent compound |
| oksiracetam | Water | AMPA | Learning acquisition |
| Aniracetam | Lipid | AMPA + nAChR | Anxiolytic |
| Nefiracetam | Lipid | AMPA + GABA-A | GABAergic modulation |
| Pramiracetam | Lipid | AMPA | Potent memory enhancement |
Important regulatory note: Nefiracetam is not FDA-approved for medical use in the United States. It has been investigated in clinical trials (including for Alzheimer’s disease and stroke recovery) but was not approved. It is available as a research chemical for laboratory use only. LyvBio supplies Nefiracetam strictly for research and development purposes.
Nefiracetam is a hydrophobic derivative of piracetam, which is generally considered to be a substance responsible for the discovery of calcium channels in the body and the indirect transfer of excitatory signaling substances as a partial agonist of calcium ion channels. Glycine binding site of NDMA receptor.
Through its effect on the cerebral cortex, nefiracetam can enhance cognitive abilities and prevent learning and memory impairment.
It does not possess muscarinic receptor agonist or antagonist properties, nor does it inhibit acetylcholinease activity.
Therefore, its anti-amnestic and memory-enhancing effects are achieved by improving the release of acetylcholine in the cerebral cortex.
| Produkt | Nr CAS. | Kategoria | Wniosek badawczy |
|---|---|---|---|
| Piracetam | 7491-74-9 | Racetam | Badania nad pamięcią, badania porównawcze |
| Aniracetam | 72432-10-1 | Racetam | AMPA + anxiolytic research |
| oksiracetam | 62613-82-5 | Racetam | Learning acquisition research |
| Pramiracetam | 68497-62-1 | Racetam | Potent memory enhancement |
| fenylopiracetam | 77472-70-9 | Racetam | Badania nad środkami pobudzającymi i funkcjami poznawczymi |
| Noopept (GVS-111) | 157115-85-0 | Dipeptyd | Neuroprotection + cognition |
LyvBio Sp. z o.o. jest certyfikowanym zgodnie z GMP dostawcą oksiracetamu o wysokiej czystości, przeznaczonego do zastosowań badawczo-rozwojowych.
Możliwości dostawcze:
Oznaczenie (HPLC): ≥99,01 TP3T
Formularz: Proszek krystaliczny
Miesięczna wydajność: 10+ kg
Duże ilości: 5g – 10kg
Czas realizacji: 3–5 dni (próbki), 10–15 dni (towar luzem)
Dokumentacja: COA, MSDS, TDS, chromatogram HPLC, dane dotyczące stabilności
Zapewnienie jakości:
Czystość określona metodą HPLC z detekcją UV
Zbadano zawartość pozostałości rozpuszczalników (zgodność z normą USP )
Badane metale ciężkie (ICP-MS)
Potwierdzenie struktury (NMR na życzenie)
📧 E-mail: info@lyvbio.com
🌐 Strona internetowa: https://www.lyvbio.com
English English 
Russian
French
Korean
German
Polish
Japanese
Spanish
Italian
Vietnamese